Neurophysiological and Genetic Findings in Patients With Juvenile Myoclonic Epilepsy.

genetics juvenile myoclonic epilepsy neurophysiology polymorphism polyphasia transcranial magnetic stimulation whole exome sequencing

Journal

Frontiers in integrative neuroscience
ISSN: 1662-5145
Titre abrégé: Front Integr Neurosci
Pays: Switzerland
ID NLM: 101477950

Informations de publication

Date de publication:
2020
Historique:
received: 31 03 2020
accepted: 21 07 2020
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 26 9 2020
Statut: epublish

Résumé

Transcranial magnetic stimulation (TMS), a non-invasive procedure, stimulates the cortex evaluating the central motor pathways. The response is called motor evoked potential (MEP). Polyphasia results when the response crosses the baseline more than twice (zero crossing). Recent research shows MEP polyphasia in patients with generalized genetic epilepsy (GGE) and their first-degree relatives compared with controls. Juvenile Myoclonic Epilepsy (JME), a GGE type, is not well studied regarding polyphasia. In our study, we assessed polyphasia appearance probability with TMS in JME patients, their healthy first-degree relatives and controls. Two genetic approaches were applied to uncover genetic association with polyphasia. 20 JME patients, 23 first-degree relatives and 30 controls underwent TMS, obtaining 10-15 MEPs per participant. We evaluated MEP mean number of phases, proportion of MEP trials displaying polyphasia for each subject and variability between groups. Participants underwent whole exome sequencing (WES) via trio-based analysis and two-case scenario. Extensive bioinformatics analysis was applied. We identified increased polyphasia in patients (85%) and relatives (70%) compared to controls (47%) and significantly higher mean number of zero crossings (i.e., occurrence of phases) (patients 1.49, relatives 1.46, controls 1.22; Polyphasia was present in JME patients and relatives in contrast to controls. Although no known clinical symptoms are linked to polyphasia this neurophysiological phenomenon is likely due to common cerebral electrophysiological abnormality. We did not discover direct association between genetic variants obtained and polyphasia. It is likely these genetic traits alone cannot provoke polyphasia, however, this predisposition combined with disturbed brain-electrical activity and tendency to generate seizures may increase the risk of developing polyphasia, mainly in patients and relatives.

Identifiants

pubmed: 32973469
doi: 10.3389/fnint.2020.00045
pmc: PMC7468511
doi:

Types de publication

Journal Article

Langues

eng

Pagination

45

Subventions

Organisme : NHGRI NIH HHS
ID : U01 HG009088
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG008895
Pays : United States

Informations de copyright

Copyright © 2020 Stefani, Kousiappa, Nicolaou, Papathanasiou, Oulas, Fanis, Neocleous, Phylactou, Spyrou and Papacostas.

Références

Acta Neurol Belg. 2000 Dec;100(4):201-13
pubmed: 11233674
Seizure. 2016 Aug;40:33-41
pubmed: 27343727
Mol Med Rep. 2017 Jul;16(1):11-22
pubmed: 28534947
PLoS One. 2018 Aug 29;13(8):e0203137
pubmed: 30157263
Epilepsia. 2000 Sep;41(9):1129-38
pubmed: 10999552
Front Neurol. 2017 Sep 25;8:499
pubmed: 28993753
Eur J Epidemiol. 2011 Apr;26(4):261-4
pubmed: 21431839
Brain Sci. 2019 Oct 18;9(10):
pubmed: 31635298
Genet Med. 2017 Feb;19(2):144-156
pubmed: 27467453
Epileptic Disord. 2018 Apr 1;20(2):77-87
pubmed: 29620013
Neurology. 2004 Dec 14;63(11):2051-5
pubmed: 15596749
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Brain. 2013 Apr;136(Pt 4):1177-91
pubmed: 23485850
Lancet. 1985 May 11;1(8437):1106-7
pubmed: 2860322
Am J Hum Genet. 2019 Aug 1;105(2):267-282
pubmed: 31327507
Epilepsy Behav. 2013 Jul;28 Suppl 1:S30-9
pubmed: 23756477
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Epilepsy Curr. 2007 May-Jun;7(3):61-7
pubmed: 17520076
Nat Neurosci. 2006 Sep;9(9):1142-9
pubmed: 16921370
Genome Med. 2015 Aug 25;7:91
pubmed: 26302787
J Neurol Neurosurg Psychiatry. 2001 Dec;71(6):772-6
pubmed: 11723199
Am J Hum Genet. 2011 Aug 12;89(2):320-7
pubmed: 21835308
Neurology. 2007 Feb 13;68(7):484-8
pubmed: 17296913
Epilepsy Behav. 2013 Jul;28 Suppl 1:S52-7
pubmed: 23756480
Clin Neurophysiol. 2015 Jun;126(6):1071-1107
pubmed: 25797650
Ann Neurol. 2007 Apr;61(4):324-31
pubmed: 17358004
Neurology. 2015 Mar 31;84(13):1301-7
pubmed: 25740859
Handb Clin Neurol. 2013;113:1701-6
pubmed: 23622391
Curr Pharm Des. 2015;21(13):1723-40
pubmed: 25412650
Curr Neurol Neurosci Rep. 2017 Feb;17(2):11
pubmed: 28229395
Clin Neurophysiol. 2009 Dec;120(12):2008-2039
pubmed: 19833552
Epilepsia. 2012 Aug;53(8):1387-98
pubmed: 22612257
Epilepsy Behav. 2013 Jul;28 Suppl 1:S87-90
pubmed: 23756490
Seizure. 2017 Jul;49:36-41
pubmed: 28544889
Seizure. 2011 Jan;20(1):42-8
pubmed: 21041102
Clin Neurophysiol. 1999 Jun;110(6):1123-32
pubmed: 10402100
Front Integr Neurosci. 2019 Oct 30;13:57
pubmed: 31736722
Epilepsy Res. 2015 Aug;114:2-12
pubmed: 26088880
Epileptic Disord. 2016 Sep 1;18(S2):73-88
pubmed: 27629553
Pharmacol Rev. 2018 Jan;70(1):142-173
pubmed: 29263209
Seizure. 2009 Jul;18(6):387-91
pubmed: 19297206
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Bioinformatics. 2019 Mar 1;35(5):889-891
pubmed: 30124768
Neurosci Behav Physiol. 2007 Nov;37(9):849-52
pubmed: 17955376
Curr Top Med Chem. 2005;5(1):59-67
pubmed: 15638778
Indian J Med Res. 2016 Nov;144(5):657-660
pubmed: 28361817
Ann Neurol. 1993 Sep;34(3):351-5
pubmed: 8363351
Seizure. 2017 Jan;44:48-52
pubmed: 27665373
Neurobiol Dis. 2015 Oct;82:164-175
pubmed: 26054439
J Neurosci Methods. 1997 Jun 27;74(2):113-22
pubmed: 9219881
Exp Neurol. 2009 Apr;216(2):300-5
pubmed: 19118553

Auteurs

Stefani Stefani (S)

Cyprus School of Molecular Medicine, Nicosia, Cyprus.
Neurology Clinic B, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Ioanna Kousiappa (I)

Cyprus School of Molecular Medicine, Nicosia, Cyprus.
Neurology Clinic B, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Nicoletta Nicolaou (N)

Medical School, University of Nicosia, Nicosia, Cyprus.
Centre for Neuroscience and Integrative Brain Research (CENIBRE), University of Nicosia, Nicosia, Cyprus.

Eleftherios S Papathanasiou (ES)

Cyprus School of Molecular Medicine, Nicosia, Cyprus.
Neurology Clinic B, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Anastasis Oulas (A)

Cyprus School of Molecular Medicine, Nicosia, Cyprus.
Bioinformatics Group, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Pavlos Fanis (P)

Cyprus School of Molecular Medicine, Nicosia, Cyprus.
Department of Molecular Genetics, Function & Therapy, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Vassos Neocleous (V)

Cyprus School of Molecular Medicine, Nicosia, Cyprus.
Department of Molecular Genetics, Function & Therapy, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Leonidas A Phylactou (LA)

Cyprus School of Molecular Medicine, Nicosia, Cyprus.
Department of Molecular Genetics, Function & Therapy, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

George M Spyrou (GM)

Cyprus School of Molecular Medicine, Nicosia, Cyprus.
Bioinformatics Group, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Savvas S Papacostas (SS)

Cyprus School of Molecular Medicine, Nicosia, Cyprus.
Neurology Clinic B, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Medical School, University of Nicosia, Nicosia, Cyprus.
Centre for Neuroscience and Integrative Brain Research (CENIBRE), University of Nicosia, Nicosia, Cyprus.

Classifications MeSH